MedPharm, a global topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announces a merger with Tergus Pharma, a Great Point Partners portfolio company. The combined organization will operate under the MedPharm name, establishing a leading, end-to-end CDMO with robust scientific, clinical trial manufacturing and commercial production capabilities. The merged business is well-positioned as a global leader in delivering a full suite of drug development and manufacturing services to innovators of all sizes focused on advancing topical and transepithelial pharmaceuticals.
Read the full article: MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transdermal CDMO Leader //
Source: https://www.prnewswire.com/news-releases/medpharm-ltd-and-tergus-pharma-merger-forms-topical-and-transdermal-cdmo-leader-302190719.html